| Jonathan Jay Sexton, MD | |
|
1215 Lee St, Charlottesville, VA 22908-4839 | |
| (434) 243-1000 | |
| (434) 244-7551 |
| Full Name | Jonathan Jay Sexton |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 14 Years |
| Location | 1215 Lee St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962723809 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Pinnacle Hanover | Hanover, PA | Hospital |
| Upmc Memorial | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Cardiovascular Institute Inc | 6901087006 | 105 |
| Pinnacle Health Regional Physicians | 7416228358 | 151 |
| Pinnacle Health Medical Services | 7618960493 | 942 |
News Archive
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
About half of the first batch of federal dollars meant to encourage doctors and hospitals to switch to electronic records went to providers who were converts to the technology long before the stimulus program was announced, an iWatch News analysis suggests.
City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.
› Verified 5 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
About half of the first batch of federal dollars meant to encourage doctors and hospitals to switch to electronic records went to providers who were converts to the technology long before the stimulus program was announced, an iWatch News analysis suggests.
City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.
› Verified 5 days ago
| Entity Name | Pinnacle Health Cardiovascular Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952603342 PECOS PAC ID: 6901087006 Enrollment ID: O20110223000139 |
News Archive
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
About half of the first batch of federal dollars meant to encourage doctors and hospitals to switch to electronic records went to providers who were converts to the technology long before the stimulus program was announced, an iWatch News analysis suggests.
City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.
› Verified 5 days ago
| Entity Name | Pinnacle Health Regional Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013441690 PECOS PAC ID: 7416228358 Enrollment ID: O20170810001731 |
News Archive
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
About half of the first batch of federal dollars meant to encourage doctors and hospitals to switch to electronic records went to providers who were converts to the technology long before the stimulus program was announced, an iWatch News analysis suggests.
City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Jay Sexton, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Jonathan Jay Sexton, MD 1215 Lee St, Charlottesville, VA 22908-4839 Ph: (434) 243-1000 |
News Archive
Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development.
About half of the first batch of federal dollars meant to encourage doctors and hospitals to switch to electronic records went to providers who were converts to the technology long before the stimulus program was announced, an iWatch News analysis suggests.
City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute, have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.
› Verified 5 days ago
Maneesh Koneru, Surgery Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2150 | |
Melinda L Bowles-childress, ACNP Surgery Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-3627 Fax: 434-243-9433 | |
Yazan Abu Orabi Al-adwan, MD Surgery Medicare: Medicare Enrolled Practice Location: 1300 Jefferson Park Ave, Charlottesville, VA 22903 Phone: 800-543-8814 Fax: 434-924-5539 | |
Mrs. Lauren Amber Huck, ACNPC-AG, RN Surgery Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-982-0301 | |
Bradley M. Rodgers, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-2673 Fax: 434-924-2656 | |
Michael D. Trahan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Martha Jefferson Drive, 5th Floor, Charlottesville, VA 22911 Phone: 434-654-5260 Fax: 434-654-5262 | |
Sandra Kabagambe, MD Surgery Medicare: Medicare Enrolled Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-2673 Fax: 434-924-3000 |